Prophylaxis: Who, what, when, and why?

Joel E. Gallant, Henry Masur, William G. Powderly

Research output: Contribution to journalArticlepeer-review


Chemoprophylaxis for more than a dozen opportunistic infections now allows people with HIV disease to live longer and better lives. Devising an effective regimen is a tough job, but one you can expect to be doing.

Original languageEnglish (US)
Pages (from-to)77-97
Number of pages21
JournalPatient Care
Issue number9
StatePublished - May 15 1996

ASJC Scopus subject areas

  • Leadership and Management


Dive into the research topics of 'Prophylaxis: Who, what, when, and why?'. Together they form a unique fingerprint.

Cite this